When the CDC reported a recent outbreak of extensively drug-resistant (XDR) Pseudomonas aeruginosa linked to artificial tears, IPATH’s Co-Director, Chip Schooley, requested the Pseudomonas isolates associated with the outbreak. Fortunately, IPATH was able to identify active phages, and notified the CDC that clinicians could contact IPATH if interested in using these phages.